Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cancer Research

• Publication date

  1990-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 2297696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review.

  1989cited by this paper
• Monitoring the transport and phosphorylation of 2‐deoxy‐D‐glucose in tumor cells in vivo and in vitro by 13C nuclear magnetic resonance spectroscopy

  1989cited by this paper
• A versatile multinuclear probe designed for in vivo NMR spectroscopy: Applications to subcutaneous human tumors in mice

  1988cited by this paper
• Multidrug resistance.

  1988cited by this paper
• Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

  1988cited by this paper
• Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.

  1988cited by this paper
• Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose.

  1987cited by this paper
• Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy.

  1987cited by this paper
• Multinuclear NMR Study of the Metabolism of Drug‐Sensitive and Drug‐Resistant Human Breast Cancer Cells

  1987cited by this paper
• Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.

  1986cited by this paper
• Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

  1986cited by this paper
• Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

  1986cited by this paper
• Monitoring the time course of cerebral deoxyglucose metabolism by 31P nuclear magnetic resonance spectroscopy.

  1985cited by this paper
• Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells.

  1985cited by this paper
• Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells.

  1984cited by this paper
• Positron emission tomography in the study of human tumors.

  1984cited by this paper
• Continuous perfusion of mammalian cells embedded in agarose gel threads.

  1984cited by this paper
• Starvation, deoxy-sugars, ouabain, and ATP metabolism in normal and malignant cells.

  1982cited by this paper
• Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors: I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and X-irradiation.

  1982cited by this paper
• Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

  1982cited by this paper
• Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

  1981cited by this paper
• Optimization of cancer therapy: Part III--Effects of combining 2-deoxy-D-glucose treatment with gamma-irradiation on normal mice.

  1979cited by this paper
• Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.

  1977cited by this paper
• 31P nuclear magnetic resonance studies of Ehrlich ascites tumor cells.

  1977cited by this paper
• Enzymology of cancer cells (second of two parts).

  1977cited by this paper
• Phosphorus-31 nuclear magnetic resonance detection of unexpected phosphodiesters in muscle.

  1976cited by this paper
• Some in vivo and in vitro antitumour effects of the deoxyfluoro-D-glucopyranoses.

  1973cited by this paper
• ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE

  1973cited by this paper
• Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose.

  1958cited by this paper
• Localization of the primary metabolic block produced by 2-deoxyglucose.

  1957cited by this paper
• Nuclear magnetic resonance in biology and medicine.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper

• Structure and Metabolically Oriented Efficacy of Fucoidan from Brown Alga Sargassum muticum in the Model of Colony Formation of Melanoma and Breast Cancer Cells

  2023cites this paper
• The role of cancer cell bioenergetics in dormancy and drug resistance

  2023cites this paper
• In-cell NMR: Why and how?

  2022cites this paper
• Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer

  2021cites this paper
• Carbohydrate metabolism in prostate cancer

  2021cites this paper
• Pharmacological interventions part IV: Metabolic modifiers

  2020cites this paper
• Metabolic Profiling of Human Gastric Cancer Cells Treated With Salazosulfapyridine

  2020cites this paper
• Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas

  2020cites this paper
• Development of a bioreactor system for cytotoxic evaluation of pharmacological compounds in living cells using NMR spectroscopy.

  2019cites this paper
• Isothermal kinase-triggered supramolecular assemblies as drug sensitizers

  2019cites this paper
• Effects of age on feeding response: Focus on the rostral C1 neuron and its glucoregulatory proteins.

  2019cites this paper
• Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII.

  2019cites this paper
• Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells

  2019cites this paper
• Alterations in global DNA methylation and metabolism-related genes caused by zearalenone in MCF7 and MCF10F cells

  2019cites this paper
• Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).

  2018cites this paper
• Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells

  2018cites this paper
• Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.

  2017cites this paper
• A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells

  2017cites this paper
• Improving breast cancer therapy through oestrone analogue and glycolysis inhibitor synergism

  2017influential citation
• 2‐Deoxy Glucose Modulates Expression and Biological Activity of VEGF in a SIRT‐1 Dependent Mechanism

  2017cites this paper
• Imaging and Metabolism

  2017cites this paper
• COMBINATION METHODS OF TREATING CANCER

  2017cites this paper
• Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin

  2016cites this paper
• Exploiting drug synergism to extend the application of oestrone analogues

  2016cites this paper
• Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin

  2016cites this paper
• Hexokinase II–derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells

  2016cites this paper
• Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.

  2016cites this paper
• Resistance of Glioblastomas to Radiation Therapy

  2016cites this paper
• Metabolic Suppression of a Drug‐Resistant Subpopulation in Cancer Spheroid Cells

  2016influential citation
• Research into cancer metabolomics: Towards a clinical metamorphosis.

  2015cites this paper
• Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”

  2015cites this paper
• Development and validation of cellular models for studying amyloid precursor protein isoforms.

  2015cites this paper
• 2-Deoxy-d-glucose treatment changes the Golgi apparatus architecture without blocking synthesis of complex lipids

  2015cites this paper
• Chromosomal instability causes sensitivity to metabolic stress

  2014cites this paper
• The wonders of 2‐deoxy‐d‐glucose

  2014cites this paper
• Enhanced Antitumor Immunity Contributes to the Radio-Sensitization of Ehrlich Ascites Tumor by the Glycolytic Inhibitor 2-Deoxy-D-Glucose in Mice

  2014cites this paper
• Régulation du métabolisme énergétique : étude du remodelage bioénergétique du cancer

  2014cites this paper
• Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones.

  2014cites this paper
• Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy

  2014cites this paper
• Potentiation of anti-cancer treatment by modulators of energy metabolism.

  2013cites this paper
• Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

  2013cites this paper
• Collateral Sensitivity in Drug-Resistant Tumor Cells

  2013cites this paper
• Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis.

  2013cites this paper
• Starving Tumors: Inhibition of Glycolysis Reduces Viability of Human Endometrial and Ovarian Cancer Cells and Enhances Antitumor Efficacy of GnRH Receptor-Targeted Therapies

  2013cites this paper
• Evolutionary approaches to prolong progression-free survival in breast cancer.

  2012cites this paper
• Collateral sensitivity as a strategy against cancer multidrug resistance.

  2012cites this paper
• Characterization of ovarian cancer cell metabolism and response to chemotherapy by (31)p magnetic resonance spectroscopy.

  2012cites this paper
• Chemotherapy: Too Much of a Good Thing?

  2012cites this paper
• Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.

  2011cites this paper
• Sugar-free approaches to cancer cell killing

  2011cites this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cites this paper
• Oxidative phosphorylation as a target to arrest malignant neoplasias.

  2011cites this paper
• FOXO3a Regulates Glycolysis via Transcriptional Control of Tumor Suppressor TSC1*

  2010cites this paper
• Glucose Transporter-1 as a New Therapeutic Target in Laryngeal Carcinoma

  2010cites this paper
• Sauerstoffverbrauchsmessungen an humanen Neuroblastomzellen und an isolierten Mitochondrien

  2010cites this paper
• 2-Deoxy-D-glucose regulates dedifferentiation through β-catenin pathway in rabbit articular chondrocytes

  2010cites this paper
• Distinct effects on M2-type pyruvate kinase are involved in the dimethylsulfoxide-induced modulation of cellular proliferation and degranulation of mast cells

  2009cites this paper
• Is resistance useless? Multidrug resistance and collateral sensitivity.

  2009cites this paper
• A combinatorial preclinical in vitro strategy against human glioblastoma cells. specific targeting of protein kinases, histone deacetylases and glycolysis

  2009cites this paper
• marine drugs

  2008cites this paper
• Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death

  2008cites this paper
• Laforin confers cancer resistance to energy deprivation-induced apoptosis.

  2008cites this paper
• 2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.

  2008cites this paper
• 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

  2008cites this paper
• Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose.

  2007cites this paper
• Gene expression in normal urothelium depends on location within the bladder: a possible link to bladder carcinogenesis.

  2006cites this paper
• The radiosensitization effect of 2-deoxy-D-glucose on human glioma cells

  2006cites this paper
• Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line

  2006cites this paper
• Radio-Protective Effect of 2-Deoxy-D-Glucose in Cervical Cancer Patient’s Lymphocytes Exposed in Vitro as Estimated by the Comet Assay

  2006cites this paper
• Glucose Withdrawal Induces Oxidative Stress followed by Apoptosis in Glioblastoma Cells but not in Normal Human Astrocytes

  2006cites this paper
• Advances in Brief NADH Dehydrogenase Deficiency in an Apoptosis . resistant Mutant Isolated from a Human HL-60 Leukemia Cell Line

  2006cites this paper
• Nonmetabolizable Glucose Compounds Impart Cryotolerance to Primary Rat Hepatocytes

  2006cites this paper
• In vivo magnetic resonance spectroscopy in cancer.

  2005cites this paper
• Real‐time detection of 13C NMR labeling kinetics in perfused EMT6 mouse mammary tumor cells and βHC9 mouse insulinomas

  2004influential citation
• Systems Biology and the Molecular Circuits of Cancer

  2004cites this paper
• In Vivo Cancers Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Updated

  2004cites this paper
• Applications of NMR Spectroscopy and Imaging to the Study of Immobilised Cell Physiology

  2004cites this paper
• Real-time detection of 13C NMR labeling kinetics in perfused EMT6 mouse mammary tumor cells and betaHC9 mouse insulinomas.

  2004cites this paper
• 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

  2004cites this paper
• Choline metabolites as diagnostic and therapeutic response indicators for breast cancer

  2004cites this paper
• Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies

  2004cites this paper
• Intermittent fasting and dietary supplementation with 2‐deoxy‐D‐glucose improve functional and metabolic cardiovascular risk factors in rats

  2003cites this paper
• Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

  2003cites this paper
• An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.

  2003cites this paper
• Pluronic block copolymers for overcoming drug resistance in cancer.

  2002cites this paper
• Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers.

  2002cites this paper
• Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death

  2002influential citation
• Microphysiometry in the Evaluation of Cytotoxic Drugs With Special Emphasis on the Novel Cyanoguanidine Chs 828

  2001cites this paper
• In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole.

  2001cites this paper
• Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.

  2001cites this paper
• Pilot Study of Albendazole in Patients with Advanced Malignancy

  2001cites this paper
• Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion

  2001cites this paper
• Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.

  2000cites this paper
• HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.

  2000cites this paper
• Applications of magnetic resonance in model systems: cancer therapeutics.

  2000cites this paper
• Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells.

  2000influential citation
• Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

  1999cites this paper
• Mitochondrial Phospholipid Hydroperoxide Glutathione Peroxidase Suppresses Apoptosis Mediated by a Mitochondrial Death Pathway*

  1999cites this paper
• Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.

  1999cites this paper
• Kinetics of cyclocreatine and Na+ cotransport in human breast cancer cells: mechanism of activity.

  1999cites this paper